Jingfeng Pharmaceutical: Some of the shares held by the controlling shareholder have been frozen by the judiciary, and the control may change.

Jingfeng Pharmaceuticals announced that it recently learned through a query that a portion of the shares held by its controlling shareholder, Ye Xiangwu, have been judicially frozen. The number of shares frozen this time is 48.7716 million, accounting for 43.45% of his shareholding, and 5.54% of the company's total share capital. The freezing period is from January 22, 2026, to January 21, 2029. As of the date of the announcement, Ye Xiangwu and his concerted parties have a total of 73.1223 million shares frozen, accounting for 63.76% of his shareholding, and 8.31% of the company's total share capital. The frozen shares are at risk of judicial auction and disposal, and if debts cannot be repaid in the future, the company's controlling rights may change.